T. E. Hilditch

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

P. Vasey, Stan B. Kaye, Rachel Morrison et al. · PubMed · 1999 · 691 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Plasma Gastrin, Daytime Intragastric pH, and Nocturnal Acid Output before and at 1 and 7 Months after Eradication of<i>Helicobacter pylori</i>in Duodenal Ulcer Subjects

Kenneth E.L. McColl, G M Fullarton, R. Chittajalu et al. · Scandinavian Journal of Gastroenterology · 1991 · 142 citations

Medicine, Clinical Sciences, Internal Medicine +17

Multi-modality megatherapy with [131I]metaiodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: Feasibility study of a new strategy for advanced neuroblastoma

Mark N. Gaze, T. E. Wheldon, Joseph A. O’Donoghue et al. · European Journal of Cancer · 1995 · 70 citations

Medicine, Oncology, Radiation Oncology +14

Lacrimal scintigraphy. II. Its role in the diagnosis of epiphora.

L A Amanat, T. E. Hilditch, Cynthia Kwok · British Journal of Ophthalmology · 1983 · 54 citations · Full text

Medicine, Ophthalmology, Clinical Anatomy +13

Energy Provision, Tissue Utilization, and Weight Loss in Prolonged Starvation

J Runcie, T. E. Hilditch · BMJ · 1974 · 46 citations · Full text

Life Sciences, Nutritional Sciences, Physiology +17